Manuel Aivado - Aug 20, 2024 Form 4 Insider Report for Aileron Therapeutics, Inc. (ALRN)

Role
Director
Signature
/s/ Brian Windsor, attorney-in-fact for Manuel Aivado
Stock symbol
ALRN
Transactions as of
Aug 20, 2024
Transactions value $
$0
Form type
4
Date filed
8/22/2024, 04:09 PM
Previous filing
Mar 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +2.73K $0.00 2.73K Aug 20, 2024 Common Stock 2.73K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders.

Remarks:

Exhibit 24.1 Power of Attorney